Tim Opler

Verified account

@TimOpler

Joined November 2021

821 Following

1.9K Followers

4 Posts

TimOpler retweeted

3 months ago

Biotech M&A on track to have 2nd most active year in history w/ more early stage deals. Nice summary of which funds have benefited from recent M&A from Stifel @TimOpler $XBI $IBB

daphnezohar's tweet photo. Biotech M&A on track to have 2nd most active year in history w/ more early stage deals. Nice summary of which funds have benefited from recent M&A from Stifel @TimOpler $XBI $IBB https://t.co/udCuhIcaIi

daphnezohar's tweet photo. Biotech M&A on track to have 2nd most active year in history w/ more early stage deals. Nice summary of which funds have benefited from recent M&A from Stifel @TimOpler $XBI $IBB https://t.co/udCuhIcaIi

daphnezohar's tweet photo. Biotech M&A on track to have 2nd most active year in history w/ more early stage deals. Nice summary of which funds have benefited from recent M&A from Stifel @TimOpler $XBI $IBB https://t.co/udCuhIcaIi

8

233

45

134

32K

TimOpler retweeted

9 months ago

Bullish biotech report from Stifel. Rates, risk on, M&A picking up & pharma desperate to fill patent cliff w/ $1.2 trillion of firepower, “biotech cleanse” (eg more quality names with late stage data after multi-year purge), specialist funds recovered, generalists coming back $XBI $IBB

daphnezohar's tweet photo. Bullish biotech report from Stifel. Rates, risk on, M&A picking up & pharma desperate to fill patent cliff w/ $1.2 trillion of firepower, “biotech cleanse” (eg more quality names with late stage data after multi-year purge), specialist funds recovered, generalists coming back $XBI $IBB

daphnezohar's tweet photo. Bullish biotech report from Stifel. Rates, risk on, M&A picking up & pharma desperate to fill patent cliff w/ $1.2 trillion of firepower, “biotech cleanse” (eg more quality names with late stage data after multi-year purge), specialist funds recovered, generalists coming back $XBI $IBB

daphnezohar's tweet photo. Bullish biotech report from Stifel. Rates, risk on, M&A picking up & pharma desperate to fill patent cliff w/ $1.2 trillion of firepower, “biotech cleanse” (eg more quality names with late stage data after multi-year purge), specialist funds recovered, generalists coming back $XBI $IBB

daphnezohar's tweet photo. Bullish biotech report from Stifel. Rates, risk on, M&A picking up & pharma desperate to fill patent cliff w/ $1.2 trillion of firepower, “biotech cleanse” (eg more quality names with late stage data after multi-year purge), specialist funds recovered, generalists coming back $XBI $IBB

27

378

74

227

104K

over 1 year ago

@damienics @bradloncar https://t.co/9PzDKJc9J8

2

13

1

12

660

over 3 years ago

@BertrandBio @BiotechCH @daphnezohar @JSchimmer_E @TheDawnBell @SamFazeli8 @robperez32 @LifeSciVC @mpreminger @eperlste @Seals310 https://t.co/a8G9z4xiUH

2

14

3

5

3K

Who to follow

Goose Data (wa/wa)

Biotech visionary. Looking for best drugs with goose data. Retweets mean honking endorsement.

Verified account

daily dose of biotech & healthcare commentary • founder @sleuthinsights • building software for the bioeconomy

Biotech advisor @Pharmagellan. Professor of the Practice of Biotech @tufts_biology. Lurking here; posting at @franksdavid.bsky.social.

Last Seen Users on Sotwe

Trends for you

Most Popular Users